22 days ago
NVO
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 23%
#1097 out of 4873 analysts
Average Return
+3.99%
Win Rate
28%10 out of 36
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-15 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-28 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-06 - 2023-09-05 | Buy |
Regeneron Pharmaceuticals IncREGN | +41.20% | $844.37 | $1,192.23 | 2023-08-21 - 2024-08-20 | Buy |
Abbvie IncABBV | +19.08% | $161.52 | $192.34 | 2024-04-29 - 2025-04-28 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
3 months ago
MRK
5 months ago
NVO
2 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arvinas IncARVN | 1 | Buy | $10.00 | +46.84% | Maintains | 4 days ago |
Regeneron Pharmaceuticals IncREGN | 6 | Buy | $800.00 | +46.07% | Maintains | 9 days ago |
Novo Nordisk A SNVO | 6 | Hold | $64.00 | -1.31% | Downgrades | 22 days ago |
Merck & Co IncMRK | 4 | Hold | $96.00 | +23.63% | Maintains | 3 months ago |
Abbvie IncABBV | 7 | Buy | $215.00 | +15.85% | Maintains | 3 months ago |
Replimune Group IncREPL | 3 | Buy | $27.00 | +247.49% | Maintains | 4 months ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | +0.02% | Downgrades | 10 months ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | +272.86% | Maintains | a year ago |
Amgen IncAMGN | 3 | Buy | $355.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 4 | Buy | $36.00 | N/A | Reiterates | a year ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 2 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 2 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.